PAR-25-270 - NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Research Opportunities Centering the Health of Women Across the HIV Research Continuum NOT-OD-24-119 ORWH , FIC , NCCIH , NCI , NIA , NIAAA , NIAID , NIAMS , NICHD , NIDA , NIDDK , NIMH , NIMHD , NINDS , OAR , OBSSR , SGMRO May 21, 2024 Jan 8, 2026 K99/R00, R01, R34, F32, K23, K25, K02, R15, K01, K43, R21, K24, R61/R33, K08, F30, R03, DP1, U34, F31, T32, R36
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAID , NIAMS , NCCIH , NCI Nov 23, 2021 Jan 8, 2025 R03, R21, U01, U44, R01, R34, P01, R61/R33

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
For technical issues E-mail OER Webmaster